Vitreomacular Interphase Disorders in Eyes with Proliferative Sickle Cell Retinopathy

Main Article Content

Olufemi Oderinlo
Adekunle Hassan
Ogugua Okonkwo

Abstract

Purpose: To describe the type of vitreomacula interface disorders (VID) seen in eyes with proliferative sickle cell retinopathy, based on optical coherence tomography findings and assess their effect on visual acuity.

Patients and Methods: This was a retrospective observational case study. Clinical records and imaging records were reviewed to identify all PSR cases with Fourier-domain OCT imaging showing VIDs at a single academic private-practice office location from January 1, 2015 to July 30, 2018. Identified VIDs were classified as Vitreomacula Adhesions, Vitreomacula Traction, Lamellar Macula Hole, Full Thickness Macula Hole, Epiretina membranes and Macula Pseudohole.

Results: Out of a total of 98 eyes of 78 patients with PSR evaluated, only 12 eyes had VIDs; this represents 12.2% of PSR patients. There were 3 (25%) males and 9 (75%) females with ages ranging from 32 to 64 years, a mean age of 45.42yrs [SD 10.27], 9(75%) right eyes were affected. In 9(75%) patients their genotype was SC and 3(25%) with genotype SS. PSR was at stage 3 in 6(50%) eyes, while the remaining 6(eyes) were at stage 4. The most common VID was epiretina membranes (ERM) seen in 7(58.3%)eyes, in 2(16.6%) ERMs eyes were associated with Lamella Macula Holes and in 1(8.3%) the ERM was associated with a pseudohole. VMAs were seen in in 3(25%) eyes and FTMHs were seen in 2 (16.6%) eyes. ERMs were thus seen in 7.1% (7 eyes) of the 98 eyes with PSR that were considered.

Conclusion: Epiretina membranes with or without macular holes are the most common vitreomacular interphase disorders seen in our series of eyes with proliferative sickle cell retinopathy. They were associated with mild to moderate impairment in visual acuity.

Keywords:
Vitreomacula interphase disorders, proliferative sickle cell retinopathy, macula hole, vitreomacula traction syndrome, vitreomacula adhesions, macula pseudohole.

Article Details

How to Cite
Oderinlo, O., Hassan, A., & Okonkwo, O. (2020). Vitreomacular Interphase Disorders in Eyes with Proliferative Sickle Cell Retinopathy. Ophthalmology Research: An International Journal, 12(3), 1-8. https://doi.org/10.9734/or/2020/v12i330146
Section
Short Research Article

References

Serjeant GR, Serjeant BE. Nomenclature and genetics of sickle cell disease. Sickle Cell Disease. Oxford University Press. 2001;31-40.

Osafo-Kwaako A, Kimani K, Ilako D, Akafo S, EkemI, et al. Ocular manifestations of sickle cell disease at the Korle-bu Hospital, Accra, Ghana. Eur J Ophthalmol. 2011;21 (4):484-9.

Hassan AO, Oderinlo O, Okonkwo ON. Visual outcome after laser photocoagulation for stage 4 proliferative sickle cell retinopathy. Nigerian Journal of Ophthalmology. 2004;12(1):19-22

Clarkson JG. The ocular manifestations of sickle-cell disease: a prevalence and natural history study. Trans Am Ophthalmol Soc. 1992;90:481-504.

Welch RB, Goldberg MF. Sickle cell hemoglobin and its relation to fundus abnormality. Arch Ophthalmol. 1966;75: 353-62.

Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 1971;71: 649–65.

Aniz Girach, Steve Pakola. Vitreoretina interface diseases pathophysiology, diagnosis and future treatment options. Expert Rev Ophthalmol. 2012;7(4):311-323.

Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome. Am. J. Ophthalmol. 1995;119 (1):55–61.

van Meurs JC, Bird AC, Downes SM: Pathology and treatment of Retinal vascular diseases in Sickle cell retinopathy and haemoglobinopathies. III Springer; 2009:713-34.

Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, et al. Incidence and natural history of proliferative sickle cell retinopathy: Observations from a cohort study. Ophthalmology. 2005;112:1869- 75.

Brazier DJ, Gregor ZJ, Blach RK, Porter JB, Huehns ER. Retinal detachment in patients with proliferative sickle cell retinopathy. Trans Ophthalmol Soc UK. 1986;105(Pt1):100-5.

Sebag J. Molecular biology of pharmacologic vitreolysis. Trans. Am. Ophthalmol. Soc. 2005;103:473– 494.

Smiddy WE, Green WR, Michels RG, De la Cruz Z. Ultrastructural studies of vitreomacular traction syndrome. Am. J. Ophthalmol. 1989;107(2):177– 185.

Shinoda K, Hirakata A, Hida T,Yamaguchi Y, Fukuda M, et al. Ultrastructural and immune histochemical findings in five patients with vitreomacular traction syndrome. Retina. 2000;20(3):289– 293.

Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120:2611e9.

Lalit Dandona, Rakhi Dandona. Revision of visual impairment definitions in the International Statistical Classification of Diseases. BMC Med. 2006;4:7.

[Published 2006 Mar 16]
DOI: 10.1186/1741-7015-4-7

Carney MD, Jampol LM. Epiretinal membranes in sickle cell retinopathy. Arch Ophthalmol. 1987;105(2):214-7.

Johnson MW. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc. 2005;103:537-567.

Uchino E, Uemura A, Obba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol. 2001;119: 1475-1479.

Raichand M, Dizon RV, Nagpal KC, Goldberg MF, Rabb MF et al. Macular holes associated with proliferative sickle cell retinopathy. Arch Ophthalmol. 1987;96:1592— 6.

Schubert HD. Schisis in sickle cell retinopathy. Arch. Ophthalmol 2005;123: 1607-1609.

Elagouz M, Jyothi S, Gupta B, Sivaprasad S. Sickle cell disease and the eye: Old and new concepts. Survey of Ophthalmology. 2010;55:4:359– 377.